# OnCo record paper-blinatumomab-infant-all-van-der-sluis-nejm-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-blinatumomab-infant-all-van-der-sluis-nejm-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-blinatumomab-infant-all-van-der-sluis-nejm-2023" ;
  schema:name "Blinatumomab added to chemotherapy in infant KMT2A-rearranged acute lymphoblastic leukaemia"@en ;
  schema:description "Adding a single course of the bispecific antibody blinatumomab after induction chemotherapy in infants with KMT2A-rearranged leukaemia raised two-year disease-free survival from a historical 49 percent to 82 percent, the first major advance in infant leukaemia in decades."@en ;
  schema:url <https://onco.cc/key-papers/paper-blinatumomab-infant-all-van-der-sluis-nejm-2023/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2214171>, <https://pubmed.ncbi.nlm.nih.gov/37099340/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2214171> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "van der Sluis IM, de Lorenzo P, Kotecha RS, et al." ;
  onco:cancers <https://onco.cc/cancers/all-infant/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .